C A Olson

Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.

Gilles Bénichou, Peter A. Takizawa, C A Olson et al. · The Journal of Experimental Medicine · 1992 · 271 citations · Full text

Histocompatibility, Cell Therapy, Donor-mhc Peptides +18

Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation.

Gilles Bénichou, Eugenia V. Fedoseyeva, P. Lehmann et al. · The Journal of Immunology · 1994 · 90 citations · Full text

Cell Therapy, T-regulatory Cell, Immunology +19

Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.

Gilles Bénichou, Peter A. Takizawa, P T Ho et al. · The Journal of Experimental Medicine · 1990 · 90 citations · Full text

Histocompatibility, Mhc Peptides, Allergy +15

Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecule.

Elizabeth S. Song, R Linsk, C A Olson et al. · Proceedings of the National Academy of Sciences · 1988 · 65 citations · Full text

Histocompatibility, Allospecific Cytotoxic T, Immunogenetics +15

Creation of H-2 class I epitopes using synthetic peptides: recognition by alloreactive cytotoxic T lymphocytes.

C A Olson, Lynn C. Williams, E McLaughlin-Taylor et al. · Proceedings of the National Academy of Sciences · 1989 · 41 citations · Full text

Histocompatibility, Adaptive Immune System, H-2 Class +18